SGH
NVO

Sivik Global Healthcare’s Novo Nordisk NVO Stock Holding History

Sivik Global Healthcare’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,000
Closed -$3.82M – 43
2025
Q4 		$3.82M Buy
+75,000
New +$3.84M 1.11% 34
2025
Q3 		– Sell
-100,000
Closed -$6.9M – 54
2025
Q2 		$6.9M Buy
100,000
+30,000
+43% +$2.04M 1.88% 22
2025
Q1 		$4.86M Hold
70,000
– – 2.63% 21
2024
Q4 		$6.02M Sell
70,000
-20,000
-22% -$2.16M 3.17% 10
2024
Q3 		$10.7M Hold
90,000
– – 4.54% 4
2024
Q2 		$12.8M Sell
90,000
-2,500
-3% -$331K 4.61% 3
2024
Q1 		$11.9M Buy
92,500
+2,500
+3% +$298K 2.78% 4
2023
Q4 		$9.31M Hold
90,000
– – 3.89% 5
2023
Q3 		$8.19M Sell
90,000
-10,000
-10% -$881K 4.14% 5
2023
Q2 		$8.09M Sell
100,000
-20,000
-17% -$1.63M 1.89% 7
2023
Q1 		$9.55M Buy
120,000
+20,000
+20% +$1.42M 4.1% 3
2022
Q4 		$6.77M Buy
100,000
+20,000
+25% +$1.17M 3.18% 10
2022
Q3 		$3.98M Sell
80,000
-40,000
-33% -$2.14M 2.21% 24
2022
Q2 		$6.69M Buy
120,000
+30,000
+33% +$1.66M 3.8% 8
2022
Q1 		$5M Buy
+90,000
New +$4.62M 2.06% 24
2020
Q3 		– Sell
-420,000
Closed -$7.37M – 55
2020
Q2 		$7.37M Sell
420,000
-80,000
-16% -$2.55M 2.44% 17
2020
Q1 		$8.16M Buy
+500,000
New +$14.9M 3.22% 11
2019
Q2 		– Sell
-270,000
Closed -$7.06M – 65
2019
Q1 		$7.06M Buy
+270,000
New +$6.64M 2.6% 12
2018
Q3 		– Sell
-100,000
Closed -$2.31M – 65
2018
Q2 		$2.31M Buy
+100,000
New +$2.38M 0.89% 46
2018
Q1 		– Sell
-100,000
Closed -$2.68M – 65
2017
Q4 		$2.68M Buy
+100,000
New +$2.54M 1% 49

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sivik Global Healthcare's NVO Position: Q1 2026 in Review

Sivik Global Healthcare sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 75,000 shares — an estimated $3.82M sold.

Sivik Global Healthcare first reported a position in NVO in Q4 2017 and held it in 20 quarters. The position peaked at $12.8M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sivik Global Healthcare reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Sivik Global Healthcare sold 75,000 Novo Nordisk shares in Q1 2026, an estimated $3.82M.
  • Sivik Global Healthcare first reported a position in Novo Nordisk in Q4 2017 and held it in 20 quarters.
  • Sivik Global Healthcare's Novo Nordisk position peaked at $12.8M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.